Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks.

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

This article delves into the approved weight loss drugs in India, their costs, and the growing market for such medications.

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.

During the hearing, an official from Novo Nordisk will be questioned about the pricing they charge for Ozempic and ...